Ira Marks has been named vice president of worldwide sales and marketing, at Cepheid.
Marks, who began work on Sept. 8, comes to Cepheid from Nanogen, where he was senior vice president of corporate development and international operations. Before joining Nanogen, he was president of the Raichem division of Hemagen Diagnostics, and, prior to that, held numerous positions at Bio-Rad Laboratories.
Marks’ appointment follows the naming June 30 of Joseph Smith as vice president and general counsel, and Russel Enns as vice president of regulatory and clinical affairs.
Mary Jane Cunningham has been appointed associate director of life sciences & health at Houston Advanced Research Center. She previously was director of discoveries at Kingston, Ontario-based Molecular Mining. Prior to that, she was director of pharmacogenomics at Woodlands, Texas-based Genometrix, where she oversaw the commercial development of an expression database for preclinical assessment and examined toxicity issues using high-throughput gene and protein expression microarrays.
Bjorn Bontin was appointed chief financial officer and investor relations manager at Uppsala, Sweden-based Gyros.
Bontoin previously was CFO and IR manager at the business systems company IBS.
Mathias Brandhammar, form-erly vice president for finance and administration, has become administration director at the proteomics, diagnostics, and drug discovery company.